INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "TETHERED SPIRO-HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF"

GENEVA, Oct. 20 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2025/023794) for "TETHERED SPIRO-HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF" on Apr 09, 2025. With publication no. WO/2025/217247, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LANMAN, Brian A. (c/o Amgen Inc.One Amgen Center DriveLaw - Patent Operations MS 28-5-AThousand Oaks, California 91320-1799), ALAFATE, Adili (c/o Amgen Inc.One Amgen Center DriveLaw - Patent Opera...